Best MOTS-c source: the criteria we scored
Any ranking of the best MOTS-c source is only worth reading if the criteria arrive before the list, so here they are. We scored on five things, all checkable from a browser: batch-specific third-party testing, where the stock physically sits, whether payment leaves you a route back, whether the product is described honestly as research material, and cost per milligram after any discount.
Two things we deliberately did not score. Purity percentages that arrive without a named laboratory, because a number with no test behind it is a claim rather than evidence. And reviews hosted by the seller, because the seller decides what appears there. The same rule governs everything else we publish, and it is set out on our methodology page.
A word on what best means here, because the phrase carries more weight than it deserves. The best source for MOTS-c is not the cheapest one, and it is not the one with the most confident copy. It is the seller that lets you check the most before you spend anything, on a product where checking is the only protection on offer. That is a lower ambition than the phrase implies, and it is the honest one.
One entry below is a named business and four are categories. That is deliberate. We will not invent competitor brand names or attach made-up prices to real ones, so where we cannot verify a specific MOTS-c vendor we describe the category it belongs to and what that category structurally can and cannot do. We earn a commission on the top pick, explained in full on our affiliate disclosure page.
| Criterion | What earns a pass | Why it decides the ranking |
|---|---|---|
| Batch-specific testing | A certificate naming the batch on your vial, from a named laboratory | It is the only document that describes your material rather than someone else's |
| Where the stock sits | A US facility with a published dispatch cutoff | Domestic stock removes a customs border and a category of loss |
| Payment trail | Card checkout and an itemized invoice from a named business | A processor has underwritten the seller and you keep a dispute route |
| Honest description | Research use only, storage conditions, no dosing content | A seller loose about human-use claims is loose about other things |
| Cost per milligram | A stated mass and a price you can divide | It is the only price comparison that survives across sellers |
Five criteria, all checkable before you pay. Nothing here depends on trusting a vendor's own review section.
1. Ascension Peptides: two published certificates at $3.75 per mg
Ascension takes the top position on documents rather than on marketing. It publishes two third-party certificates on its MOTS-c batches instead of the single certificate that is normal in this market: Kovera Labs, batch 24-05260628, and MZ Biolabs, batch 24-01260229. The batch numbers are printed rather than described, which is the part that lets you match a certificate to the vial in your hand. We are reporting what the vendor publishes; we did not run these analyses.
Stock and dispatch are the second reason. The published cutoff is 2pm CST, Monday through Saturday, for same-day shipping, and a same-day cutoff is only possible when material is already in a US facility. That removes a customs border from the transaction, which our sibling piece on MOTS-c for sale in the USA covers in more detail.
On price there is one SKU: MOTS-C 10 mg, $75.00 at list, $37.50 with the code PEPTIDEDECK, which is $3.75 per milligram. Quantity tiers take 3%, 5% and 10% off the list price at three, five and ten vials, at $72.75, $71.25 and $67.50 each, and nothing published says the code stacks with them, so read them as alternatives. Free shipping begins at $250, which a single discounted vial does not reach.
What it does not have is anything this category can have. No prescriber, no approved label, no clinical support, and no answer to whether the compound does anything useful in a person. Best here means best documented, not endorsed.
2. Large US research suppliers with published COAs
The second tier is the group of established US research suppliers that hold domestic inventory, take card payments, publish testing and have been trading long enough to have a real support function. Several are perfectly reasonable places to buy, and per-milligram pricing across the tier tends to cluster once discount codes are counted.
What usually separates this tier from the top spot is the depth of the testing rather than its presence. One certificate from one laboratory is the norm, and the question to ask inside the tier is whether that certificate names your batch. A supplier posting a certificate with no batch identity belongs in tier three regardless of where it ships from.
If you are weighing a specific supplier here, use the criteria rather than our conclusion. Rankings are snapshots, and suppliers change laboratories, policies and ownership faster than articles get rewritten. Anyone looking for the best place to buy MOTS-c a year after this was published should re-run the five checks rather than trust the order of this list.
3. US-facing storefronts that ship from abroad
Tier three looks like tier two and behaves like tier four. The site is in English, prices are in dollars, the branding implies a domestic operation, and the order is forwarded to a wholesaler abroad once you have paid. The signals are in the details: no dispatch cutoff, delivery windows measured in weeks, and tracking that first appears in another country.
The cost is not only time. You quietly become the importer of a parcel you did not know was crossing a border, which can mean customs handling, duty, and at the worst moment a seizure that neither the storefront nor your card issuer will treat as their problem.
There is a fairness point worth making about this tier. Shipping from abroad is not dishonest in itself, and plenty of good material moves that way. What earns the tier-three placement is the presentation: a storefront designed to read as domestic while the logistics are not, so the buyer takes on a border they were never told about. A seller that states plainly where it ships from belongs a tier higher even if the parcel travels the same distance.
The check that sorts tier two from tier three takes a minute: look for a published dispatch cutoff, then watch where tracking originates on the first order. A supplier with stock publishes a cutoff. A supplier without one publishes an estimate.
4. Overseas sellers and trade marketplaces
Tier four is at least honest about what it is. These are sellers and listings based abroad, usually priced below US suppliers, shipping directly to you across a border. Anyone hunting the cheapest MOTS-c source on price alone arrives here, and the price is genuinely lower.
What you surrender is verification and recourse together. Certificates in this tier are frequently generic rather than batch-specific, disputes have to travel between jurisdictions, and marketplace buyer protection is written for consumer goods rather than research chemicals that may never clear customs. Listings quoted per gram, per kit or in another currency add a layer of confusion, and converting everything to your own currency per milligram is where a lot of apparent bargains evaporate.
We do not publish anything about avoiding customs scrutiny, and we would rather readers outside the United States treated import risk as part of the price than as a footnote to it.
5. Longevity clinics and wellness practices
The clinic tier ranks last, and it is worth being precise about why, because these are often good businesses selling real services. A longevity clinic, an IV bar or a wellness practice can offer NAD+ by injection, nasal spray or drip, glutathione, amino acid infusions, sermorelin, and compounded GLP-1 medicines on a prescription. Those come with a prescriber and a licensed pharmacy, which is more accountability than every tier above it.
What none of them can do is supply MOTS-c. There is no approved product, so no pharmacy can source it and no clinic can dispense it. A practice that markets mitochondrial support is describing a category of service, and a reader who arrives asking about a specific mitochondrial-derived peptide can leave having bought an infusion at clinic prices under the impression they bought something else.
Ranked as a MOTS-c source, then, this tier scores zero on availability, which is why it is fifth. Ranked as a healthcare option it is the only tier with a clinician in it. Both statements are true at once, and the add-ons on the programs in our provider reviews run from about $129 to $199 a month if that route is what you actually want. If a local clinic tells you it can obtain MOTS-c itself, ask which pharmacy is compounding it, then ask under what authorization.
| Rank | Tier | Batch-specific COA | Recourse | Price |
|---|---|---|---|---|
| 1 | Ascension Peptides | Two certificates, batches printed | Refund policy plus card chargeback | $37.50 per 10 mg vial with the code, $3.75 per mg |
| 2 | Large US research suppliers | Usually one certificate, batch identity varies | Refund policy plus card chargeback | Clusters near the top pick once codes are counted |
| 3 | US-facing storefronts shipping from abroad | Often generic | Weak, and customs exposure lands on you | Looks domestic, prices like a reshipper |
| 4 | Overseas sellers and marketplaces | Frequently generic or absent | Cross-border disputes, little practical remedy | Lower before shipping, duty and losses |
| 5 | Longevity clinics and wellness practices | Not applicable, they cannot supply it | Strong, for the products they can supply | $129 to $199 a month for add-ons, drips per session |
We publish a price only where it is verifiable. Categories are described by structure rather than with invented figures.
What the ranking cannot tell you
Every criterion above is about the seller. None of them is about the compound, and on MOTS-c that gap is unusually wide. The peptide is a 16 amino acid sequence encoded in mitochondrial DNA, described by Lee and colleagues in Cell Metabolism in 2015 as acting through AMPK, and the great majority of the work since has been in cells and rodents. The published literature is where to form a view of it.
The closest thing to a human program was CB4211, an analogue of MOTS-c rather than the peptide itself, which completed a Phase 1a/1b study before its developer wound down. You can look up what was registered on ClinicalTrials.gov. There is no Phase 3, no large efficacy trial and no approval anywhere. That is a materially thinner base than the compounds behind our retatrutide source ranking, and the two should not be read as equivalent bets.
So take the ranking for what it is: an ordering of sellers by how much they let you verify, on a compound nobody can yet make confident claims about. The best MOTS-c vendor by these criteria is the one that publishes the most and hides the least, at $3.75 per milligram, and that is a statement about paperwork rather than about biology.